Balyasny Asset Management LLC Mersana Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 535,819 shares of MRSN stock, worth $728,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares
535,819
Holding current value
$728,713
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.23 - $2.25 $659,057 - $1.21 Million
535,819 New
535,819 $1.01 Million
Q1 2024

May 13, 2024
SELL
$2.16 - $5.94 $13.1 Million - $35.9 Million
-6,042,149 Reduced 62.3%
3,655,998 $16.4 Million
Q4 2023

Feb 14, 2024
BUY
$1.11 - $2.34 $5.17 Million - $10.9 Million
4,657,247 Added 92.39%
9,698,147 $22.5 Million
Q3 2023

Nov 14, 2023
BUY
$1.06 - $3.91 $213,468 - $787,415
201,385 Added 4.16%
5,040,900 $6.4 Million
Q2 2023

Aug 14, 2023
BUY
$3.08 - $9.55 $14.9 Million - $46.2 Million
4,839,515 New
4,839,515 $15.9 Million
Q4 2022

Feb 14, 2023
SELL
$5.65 - $7.86 $321,654 - $447,469
-56,930 Reduced 89.62%
6,597 $38,000
Q3 2022

Nov 14, 2022
BUY
$4.63 - $8.0 $38,327 - $66,224
8,278 Added 14.98%
63,527 $430,000
Q2 2022

Aug 15, 2022
BUY
$2.84 - $5.0 $75,896 - $133,620
26,724 Added 93.69%
55,249 $255,000
Q1 2022

May 16, 2022
BUY
$3.74 - $6.63 $51,967 - $92,123
13,895 Added 94.98%
28,525 $114,000
Q4 2021

Feb 14, 2022
BUY
$5.48 - $9.86 $80,172 - $144,251
14,630 New
14,630 $91,000
Q2 2021

Aug 16, 2021
SELL
$13.28 - $18.07 $260,766 - $354,822
-19,636 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$15.31 - $26.52 $300,627 - $520,746
19,636 New
19,636 $318,000
Q4 2020

Feb 16, 2021
SELL
$16.84 - $27.59 $2.56 Million - $4.19 Million
-151,958 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$16.2 - $25.7 $2.46 Million - $3.91 Million
151,958 New
151,958 $2.83 Million
Q4 2018

Feb 14, 2019
SELL
$3.45 - $9.72 $124,510 - $350,794
-36,090 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$10.0 - $19.02 $465,100 - $884,620
-46,510 Reduced 56.31%
36,090 $361,000
Q2 2018

Aug 14, 2018
BUY
$14.2 - $22.68 $1.17 Million - $1.87 Million
82,600 New
82,600 $1.48 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $132M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email